"One thing we're seeing is that a lot of things about sickle cell disease have not changed. It's still a racialized disease. It's still a disease with tremendous health care disparities," says Pecker, ...

PAUL TALKS ABOUT WHAT IT’S LIKE TO LIVE WITH SICKLE CELL DISEASE. HE AND HIS BROTHER BRETT PAUL. WE’RE BOTH TREATED AT JOHNS HOPKINS FOR THE DISEASE DEAN PAUL FOR DECADES. PUT HIS BODY ON THE ...

Current gene therapies to treat sickle cell disease are complex, time-consuming, and are sometimes linked to serious side effects like infertility or blood cancer. To address these challenges, Johns ...

A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative ...

Scientists from Johns ... Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have identified a potential new gene target that could be edited to treat ...

A bone marrow transplant process is safe and curative for adults with sickle cell disease, according to results of a trial completed at about 20 cancer centers. A bone marrow transplant process co ...

Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research ...

“That’s the central question,” said Lydia Pecker, the lead author of the study and interim director of the Johns Hopkins sickle cell center for adults. “Is this a phenomenon that mirrors ...

Black patients tend to have less social capital and fewer resources, according to Dr. Lydia Pecker, a sickle cell disease researcher and assistant professor of medicine at Johns Hopkins University.